BOXED WARNING Severe and sometimes fatal hepatitis; risk is age-related and increased by daily alcohol use — monitor symptoms monthly and hepatic enzymes (AST/ALT) in patients ≥35.
FDA dosing
Population
Start
Target
Max
Active tuberculosis (with other agents)
Adult
5 mg/kg up to 300 mg QD
15 mg/kg up to 900 mg 2-3x/week (intermittent)
Active tuberculosis (with other agents)
Children
10-15 mg/kg up to 300 mg QD
20-40 mg/kg up to 900 mg 2-3x/week (intermittent)
TB preventive therapy
Adults >30 kg
300 mg QD
20-30 mg/kg up to 900 mg twice weekly
TB preventive therapy
Infants/children
10 mg/kg up to 300 mg QD
20-30 mg/kg up to 900 mg twice weekly
Renal Undefined
Hepatic Undefined
Instructions
Give as a single daily dose
Concomitant pyridoxine (B6) recommended in the malnourished and those predisposed to neuropathy (alcoholics, diabetics)
Intermittent (2-3x/week) regimens should be given by directly observed therapy
Contraindications
Previous isoniazid-associated hepatic injury
Prior severe reaction to isoniazid (drug fever, chills, arthritis)
Acute liver disease of any etiology
Cautions
Hepatotoxicity, including fatal hepatitis (see boxed warning)